Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASCEND: Adjuvant 5-Fluorouracil Following Thermal Ablation for HPV in Women With HIV
NCT07545746Phase 2Not yet recruiting
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Start
- Sep 2026
- Primary completion
- Sep 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fluorouracil in human papillomavirus infection, cervical intraepithelial neoplasia (CIN), sponsored by UNC Lineberger Comprehensive Cancer Center. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
fluorouracil
03
Conditions
human papillomavirus infectioncervical intraepithelial neoplasia (CIN)
Beyond the preview
Go deeper on NCT07545746.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07545746.